Loading stock…

Elis SA (ELIS) Stock Verdict & Ratings | Investment Bastion

02Growth

Is it actually growing, and how fast?

ELISElis

Revenue FY25$5.6B

GROWTH RATING↗

WEAK34 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+11%7

Revenue, next 1Y+1%3

Revenue, next 3Y, CAGR+4%4

Revenue, next 5Y, CAGR+4%3

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+41%9

EPS growth, FY27E+7%6

EPS growth, FY28E+6%5

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 11%/yr over the last 3 years, ahead of 60% of companies worldwide.7/10

Earnings are set to grow in step with sales (EPS about 7%/yr vs revenue 4%/yr).

WATCH

A mid-pack grower, ahead of 34% of companies worldwide.

Revenue grew 11%/yr over the last 3 years; forecasts see it cooling to 4%/yr.

WEAKNESSES

Revenue is set to grow 4%/yr over the next 3 years, behind most of the market.3/10

Over five years revenue is set to grow 4%/yr, behind 70% of companies worldwide.3/10

BOTTOM LINE

Margin Expander

A middle-of-the-pack grower that is slowing. The one thing to watch: forward revenue growth trails the market.

03Price Momentum

Is the market behind it right now?

ELISElis

Total return Current58.5%

Price return Current36.4%

MOMENTUM RATING↗

WEAK26 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-6%4

3-month return-20%2

YTD return-10%3

MID & LONG-TERM▾SCORE

% of 52-week high76%4

1-year return-8%4

3-year return+37%5

5-year return+47%6

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

Average long-term results. Multi-year returns are middling (+37% over three years and +47% over five), roughly average for the market.

It's down 8% over the past year, now 24% below its 52-week high. That is a touch behind the market.

Returns sit at the market level over the past month (-6%).

WEAKNESSES

The stock is underperforming over three months (-20%) and so far this year (-10%).

BOTTOM LINE

Falling Knife

Returns rank poorly over both the short and long run, and the price is still falling. Momentum is firmly negative — catching this is a bet against the tape, not with it. Wait for a base to form. The one thing to watch: the stock is underperforming over three months and so far this year.

04Value

Are you paying a fair price for it?

Stop guessing on Elis SA. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

ELISElis

Revenue FY25$5.6B

GROWTH RATING↗

WEAK34 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+11%7

Revenue, next 1Y+1%3

Revenue, next 3Y, CAGR+4%4

Revenue, next 5Y, CAGR+4%3

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+41%9

EPS growth, FY27E+7%6

EPS growth, FY28E+6%5

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 11%/yr over the last 3 years, ahead of 60% of companies worldwide.7/10

Earnings are set to grow in step with sales (EPS about 7%/yr vs revenue 4%/yr).

WATCH

A mid-pack grower, ahead of 34% of companies worldwide.

Revenue grew 11%/yr over the last 3 years; forecasts see it cooling to 4%/yr.

WEAKNESSES

Revenue is set to grow 4%/yr over the next 3 years, behind most of the market.3/10

Over five years revenue is set to grow 4%/yr, behind 70% of companies worldwide.3/10

BOTTOM LINE

Margin Expander

A middle-of-the-pack grower that is slowing. The one thing to watch: forward revenue growth trails the market.

03Price Momentum

Is the market behind it right now?

ELISElis

Total return Current58.5%

Price return Current36.4%

MOMENTUM RATING↗

WEAK26 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-6%4

3-month return-20%2

YTD return-10%3

MID & LONG-TERM▾SCORE

% of 52-week high76%4

1-year return-8%4

3-year return+37%5

5-year return+47%6

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

Average long-term results. Multi-year returns are middling (+37% over three years and +47% over five), roughly average for the market.

It's down 8% over the past year, now 24% below its 52-week high. That is a touch behind the market.

Returns sit at the market level over the past month (-6%).

WEAKNESSES

The stock is underperforming over three months (-20%) and so far this year (-10%).

BOTTOM LINE

Falling Knife

04Value

Are you paying a fair price for it?

Stop guessing on Elis SA. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Elis SA

01Key Ratings

02Growth

03Price Momentum

04Value

Stop guessing on Elis SA. Get the full investment case.

Premium

02Growth

03Price Momentum

04Value

Stop guessing on Elis SA. Get the full investment case.

Premium